Michael S. Lee

14.6k total citations · 1 hit paper
162 papers, 6.7k citations indexed

About

Michael S. Lee is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Michael S. Lee has authored 162 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 37 papers in Pathology and Forensic Medicine and 27 papers in Neurology. Recurrent topics in Michael S. Lee's work include Protein Structure and Dynamics (25 papers), Ophthalmology and Eye Disorders (21 papers) and Colorectal Cancer Treatments and Studies (14 papers). Michael S. Lee is often cited by papers focused on Protein Structure and Dynamics (25 papers), Ophthalmology and Eye Disorders (21 papers) and Colorectal Cancer Treatments and Studies (14 papers). Michael S. Lee collaborates with scholars based in United States, Netherlands and Italy. Michael S. Lee's co-authors include Charles L. Brooks, Freddie R. Salsbury, Wonpil Im, Mark A. Olson, Michael Feig, Martin Head‐Gordon, Richard N. Trelease, Scott Kopetz, Robert T. Mullen and David G. Menter and has published in prestigious journals such as The Journal of Chemical Physics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael S. Lee

151 papers receiving 6.5k citations

Hit Papers

Generalized born model with a simple smoothing function 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Lee United States 37 3.2k 1.1k 832 705 602 162 6.7k
Minoru Sakurai Japan 44 2.9k 0.9× 608 0.6× 642 0.8× 787 1.1× 212 0.4× 392 8.1k
Takashi Yamazaki Japan 43 2.2k 0.7× 805 0.7× 596 0.7× 186 0.3× 468 0.8× 479 8.9k
Fang Ye China 48 4.5k 1.4× 496 0.5× 351 0.4× 693 1.0× 215 0.4× 388 8.7k
Isao Tanaka Japan 60 5.9k 1.8× 1.1k 1.0× 3.5k 4.2× 737 1.0× 250 0.4× 621 15.8k
Atsushi Ogata Japan 49 2.4k 0.7× 573 0.5× 331 0.4× 1.6k 2.2× 654 1.1× 227 7.5k
Andrew D. Robertson United States 43 4.0k 1.2× 429 0.4× 1.3k 1.6× 296 0.4× 123 0.2× 115 7.0k
Larry A. Sklar United States 71 10.5k 3.3× 344 0.3× 734 0.9× 2.1k 3.0× 378 0.6× 319 19.1k
David S. Hsu United States 47 4.3k 1.3× 378 0.3× 773 0.9× 2.1k 3.0× 539 0.9× 184 9.1k
Marcel B. Bally Canada 62 9.3k 2.9× 308 0.3× 867 1.0× 2.4k 3.4× 354 0.6× 263 15.3k
Karl Harlos United Kingdom 59 5.4k 1.7× 260 0.2× 819 1.0× 998 1.4× 305 0.5× 156 10.5k

Countries citing papers authored by Michael S. Lee

Since Specialization
Citations

This map shows the geographic impact of Michael S. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Lee more than expected).

Fields of papers citing papers by Michael S. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Lee. The network helps show where Michael S. Lee may publish in the future.

Co-authorship network of co-authors of Michael S. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Lee. A scholar is included among the top collaborators of Michael S. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Lee. Michael S. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Ayyub, Rana Muhammad, et al.. (2024). Ethnic foods serving cultural bridge or barrier? A systematic literature review. International Journal of Intercultural Relations. 102. 102011–102011.
4.
Sanoff, Hanna K., Allison M. Deal, Jai N. Patel, et al.. (2024). A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer. The Oncologist. 29(9). 786–793. 1 indexed citations
5.
Thomas, Jane V., Kaysia Ludford, Jason Willis, et al.. (2023). Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer Research Communications. 3(12). 2510–2517. 4 indexed citations
6.
Lee, Michael S., Ahmed O. Kaseb, & Shubham Pant. (2023). The Emerging Role of Circulating Tumor DNA in Non-Colorectal Gastrointestinal Cancers. Clinical Cancer Research. 29(17). 3267–3274. 7 indexed citations
7.
Sorokin, Alexey V., Preeti Kanikarla Marie, Ganiraju C. Manyam, et al.. (2022). Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6. Cancer Research. 82(18). 3335–3344. 37 indexed citations
8.
Moore, Dominic T., Matthew J. Reilley, Mohamed E. Salem, et al.. (2022). Phase II Single-Arm Study of Palbociclib and Cetuximab Rechallenge in Patients with KRAS/NRAS/BRAF Wild-Type Colorectal Cancer. The Oncologist. 27(12). 1006–e930. 9 indexed citations
9.
Liu, Yingmiao, Jing Lyu, Kirsten B. Burdett, et al.. (2020). Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib. Molecular Cancer Therapeutics. 19(10). 2146–2154. 15 indexed citations
10.
Sanoff, Hanna K., Dominic H. Moon, Dominic T. Moore, et al.. (2019). Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer. Nanomedicine Nanotechnology Biology and Medicine. 18. 189–195. 53 indexed citations
11.
McLoon, Linda K., et al.. (2019). Electoretinographic evidence of retinal ganglion cell-dependent function in schizophrenia. Schizophrenia Research. 219. 34–46. 16 indexed citations
12.
Lee, Michael S., et al.. (2017). Strabismus Measurements in Adults Before and After Pupil Dilation. American Journal of Ophthalmology. 178. 1–8.
13.
McClelland, Collin M., Georgios Manousakis, & Michael S. Lee. (2016). Progressive External Ophthalmoplegia. Current Neurology and Neuroscience Reports. 16(6). 53–53. 57 indexed citations
14.
Tang, Peter H., et al.. (2016). Atypical Leber Hereditary Optic Neuropathy: 18 Year Interval Between Eyes. Journal of Neuro-Ophthalmology. 36(3). 304–304. 10 indexed citations
15.
Tamhankar, Madhura A., Valérie Biousse, Gui‐Shuang Ying, et al.. (2013). Isolated Third, Fourth, and Sixth Cranial Nerve Palsies from Presumed Microvascular versus Other Causes. Ophthalmology. 120(11). 2264–2269. 133 indexed citations
16.
Kugelman, Jeffrey R., Michael S. Lee, Cynthia A. Rossi, et al.. (2012). Ebola Virus Genome Plasticity as a Marker of Its Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection. PLoS ONE. 7(11). e50316–e50316. 34 indexed citations
17.
Harrison, Andrew R., et al.. (2010). Ocular treatment of thyroid eye disease. Expert Review of Ophthalmology. 5(3). 313–325. 6 indexed citations
18.
Johnson, Matthew, Michael S. Lee, Brian R. Younge, & Valerie A. Purvin. (2010). Multiple Sclerosis on Steroids. Survey of Ophthalmology. 55(5). 460–466. 1 indexed citations
19.
Olson, Mark A., In‐Chul Yeh, & Michael S. Lee. (2008). Molecular Dynamics Simulations of Folding and Insertion of the Ebola Virus Fusion Peptide into a Membrane Bilayer. 660–665. 1 indexed citations
20.
Schmid, Kara, Michael S. Lee, James M. Meegan, et al.. (2008). Extensive Antibody Cross-reactivity among Infectious Gram-negative Bacteria Revealed by Proteome Microarray Analysis. Molecular & Cellular Proteomics. 8(5). 924–935. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026